North America Automated Cell Counters Market
The North America Automated Cell Counters Market size was valued at US$ 2,908.97 Mn in 2022 and is projected to reach US$ 4,146.38 Mn by 2028, growing at a CAGR of 6.1% during 2022 - 2028.
Report Coverage
- Type: Hemocytometer, Flow Cytometers, Electrical Impedance Coulter Counters, Spectrophotometers
- End User: Hospitals, Research Laboratories, Diagnostics Centers
US$ 2,908.97 Mn
Market size in 2022
US$ 4,146.38 Mn
Market Size by 2028
6.1%
CAGR, 2022 - 2028
2023-2028
Forecast Period
1. Introduction
1.1 Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Market Insights
2.2 Market Attractiveness
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Data Triangulation and Validation
4. North America Automated Cell Counters Market Landscape
4.1 Overview
4.3 Ecosystem Analysis
- 4.3.1 List of Vendors in the Value Chain
5. North America Automated Cell Counters Market – Key Market Dynamics
5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints
6. North America Automated Cell Counters Market Regional Analysis
6.2 North America Automated Cell Counters Market Revenue 2020-2028 (US$ Million)
6.3 North America Automated Cell Counters Market Forecast Analysis
7. North America Automated Cell Counters Market Analysis – by Type
7.1 Hemocytometer
- 7.1.1 Overview
- 7.1.2 Hemocytometer: North America Automated Cell Counters Market – Revenue and Forecast, 2020-2028 (US$ Million)
7.2 Flow Cytometers
- 7.2.1 Overview
- 7.2.2 Flow Cytometers: North America Automated Cell Counters Market – Revenue and Forecast, 2020-2028 (US$ Million)
7.3 Electrical Impedance Coulter Counters
- 7.3.1 Overview
- 7.3.2 Electrical Impedance Coulter Counters: North America Automated Cell Counters Market – Revenue and Forecast, 2020-2028 (US$ Million)
7.4 Spectrophotometers
- 7.4.1 Overview
- 7.4.2 Spectrophotometers: North America Automated Cell Counters Market – Revenue and Forecast, 2020-2028 (US$ Million)
8. North America Automated Cell Counters Market Analysis – by End User
8.1 Hospitals
- 8.1.1 Overview
- 8.1.2 Hospitals: North America Automated Cell Counters Market – Revenue and Forecast, 2020-2028 (US$ Million)
8.2 Research Laboratories
- 8.2.1 Overview
- 8.2.2 Research Laboratories: North America Automated Cell Counters Market – Revenue and Forecast, 2020-2028 (US$ Million)
8.3 Diagnostics Centers
- 8.3.1 Overview
- 8.3.2 Diagnostics Centers: North America Automated Cell Counters Market – Revenue and Forecast, 2020-2028 (US$ Million)
9. North America Automated Cell Counters Market – North America Analysis
9.1 Overview
9.2 North America- 9.2.1 North America Automated Cell Counters Market Breakdown, by Key Country, 2023 and 2028 (%)
- 9.2.1.1 North America Automated Cell Counters Market – Revenue and Forecast Analysis – by Country
- 9.2.1.1 US: North America Automated Cell Counters Market – Revenue and Forecast to 2028 (US$ Million)
- 9.2.1.1.1 US: North America Automated Cell Counters Market Breakdown, by Type
- 9.2.1.1.2 US: North America Automated Cell Counters Market Breakdown, by End User
- 9.2.1.2 Canada: North America Automated Cell Counters Market – Revenue and Forecast to 2028 (US$ Million)
- 9.2.1.2.1 Canada: North America Automated Cell Counters Market Breakdown, by Type
- 9.2.1.2.2 Canada: North America Automated Cell Counters Market Breakdown, by End User
- 9.2.1.3 Mexico : North America Automated Cell Counters Market – Revenue and Forecast to 2028 (US$ Million)
- 9.2.1.3.1 Mexico : North America Automated Cell Counters Market Breakdown, by Type
- 9.2.1.3.2 Mexico : North America Automated Cell Counters Market Breakdown, by End User
10. Competitive Landscape
10.1 Heat Map Analysis
10.2 Company Positioning and Concentration
11. Industry Landscape
11.1 Overview
11.2 Market Initiative
11.3 Partnerships and Collaborations
11.4 Other Developments
12. Company Profiles
12.1 Eppendorf
- 12.1.1 Key Facts
- 12.1.2 Business Description
- 12.1.3 Products and Services
- 12.1.4 Financial Overview
- 12.1.5 SWOT Analysis
- 12.1.6 Key Developments
12.2 Thermo Fisher Scientific Inc.
- 12.2.1 Key Facts
- 12.2.2 Business Description
- 12.2.3 Products and Services
- 12.2.4 Financial Overview
- 12.2.5 SWOT Analysis
- 12.2.6 Key Developments
12.3 Countstar Inc.
- 12.3.1 Key Facts
- 12.3.2 Business Description
- 12.3.3 Products and Services
- 12.3.4 Financial Overview
- 12.3.5 SWOT Analysis
- 12.3.6 Key Developments
12.4 Bio-Rad Laboratories, Inc.
- 12.4.1 Key Facts
- 12.4.2 Business Description
- 12.4.3 Products and Services
- 12.4.4 Financial Overview
- 12.4.5 SWOT Analysis
- 12.4.6 Key Developments
12.5 F. Hoffman-La Roche Ltd
- 12.5.1 Key Facts
- 12.5.2 Business Description
- 12.5.3 Products and Services
- 12.5.4 Financial Overview
- 12.5.5 SWOT Analysis
- 12.5.6 Key Developments
12.6 Chemometec A/S
- 12.6.1 Key Facts
- 12.6.2 Business Description
- 12.6.3 Products and Services
- 12.6.4 Financial Overview
- 12.6.5 SWOT Analysis
- 12.6.6 Key Developments
12.7 ALIGNED GENETICS
- 12.7.1 Key Facts
- 12.7.2 Business Description
- 12.7.3 Products and Services
- 12.7.4 Financial Overview
- 12.7.5 SWOT Analysis
- 12.7.6 Key Developments
12.8 Beckman Coulter, Inc. (Danaher)
- 12.8.1 Key Facts
- 12.8.2 Business Description
- 12.8.3 Products and Services
- 12.8.4 Financial Overview
- 12.8.5 SWOT Analysis
- 12.8.6 Key Developments
12.9 Nanoentek
- 12.9.1 Key Facts
- 12.9.2 Business Description
- 12.9.3 Products and Services
- 12.9.4 Financial Overview
- 12.9.5 SWOT Analysis
- 12.9.6 Key Developments
12.10 Olympus Corporation
- 12.10.1 Key Facts
- 12.10.2 Business Description
- 12.10.3 Products and Services
- 12.10.4 Financial Overview
- 12.10.5 SWOT Analysis
- 12.10.6 Key Developments
12.11 MERCK KGaA
- 12.11.1 Key Facts
- 12.11.2 Business Description
- 12.11.3 Products and Services
- 12.11.4 Financial Overview
- 12.11.5 SWOT Analysis
- 12.11.6 Key Developments
12.12 Sysmex Corporation
- 12.12.1 Key Facts
- 12.12.2 Business Description
- 12.12.3 Products and Services
- 12.12.4 Financial Overview
- 12.12.5 SWOT Analysis
- 12.12.6 Key Developments
12.13 Agilent Technologies, Inc.
- 12.13.1 Key Facts
- 12.13.2 Business Description
- 12.13.3 Products and Services
- 12.13.4 Financial Overview
- 12.13.5 SWOT Analysis
- 12.13.6 Key Developments
12.14 Abbott
- 12.14.1 Key Facts
- 12.14.2 Business Description
- 12.14.3 Products and Services
- 12.14.4 Financial Overview
- 12.14.5 SWOT Analysis
- 12.14.6 Key Developments
12.15 Nexcelom Bioscience LLC.
- 12.15.1 Key Facts
- 12.15.2 Business Description
- 12.15.3 Products and Services
- 12.15.4 Financial Overview
- 12.15.5 SWOT Analysis
- 12.15.6 Key Developments
13. Appendix
13.1 About Business Market Insights
13.2 List of Abbreviations
Access the Full N Market Report
Get segment-level forecasts, regional estimates, competitive benchmarking, company profiles and downloadable Excel datasets.
